±ÇÖиô,Nasal septumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ö»¯Ðͼ××´ÏÙ°©,differentiated thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹Ìå±ú,Pituitary stalkÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÖ×Áö/²¡Àíѧ,thyroid neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓҰȱËð,visual field defectÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­µûñ¼Èë·,transsphenoidal approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶¯Ì¬ÇúÏß,dynamic curveÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹Ìå×äÖÐ,pituitary apoplexyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÛ±íÏÖ,eye manifestationsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓ½»²æ,optic chiasmÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êõºó·ÅÉäÖÎÁÆ,Postoperative radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­µûñ¼ÊÖÊõ,transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇÖÏ®ÐÔ´¹ÌåÏÙÁö,invasive pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓÓÕ·¢µçλ,visual evoked potentialÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÆ¤ÖÊÖ×Áö,adrenocortical tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÖ×Áö/Õï¶Ï,Thyroid neoplasms/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µòÍöÒÖÖÆµ°°×ÖÊÀà,Inhibitor of apoptosis proteinsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈéÍ·×´¼××´ÏÙ°©,papillary thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÆ¤Öʰ©,adrenocortical carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Merkelϸ°û°©,Merkel cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙËèÖÊÖ¬·¾Áö,Adrenal myelolipomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CT·ÂÕæÄÚ¾µ,CT virtual endoscopyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚÔ´ÐÔ¼×È©,Endogenous formaldehydeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶à·¢ÐÔÄÚ·ÖÃÚÏÙÁö²¡2aÐÍ,Multiple endocrine neoplasia type 2aÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂËÅݰ©,Follicular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±Áܰͽá×ªÒÆ,cervical lymph node metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ñÐÔÊȸõϸ°ûÁö,Malignant pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍ¸Æ,low calciumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖØÖ¢¼¡ÎÞÁ¦(MG),Myasthenia gravis (MG)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙ°©,Thymic carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙż·¢Áö,adrenal incidentalomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« È«Éí¹ÇɨÃè,whole body bone scanÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙδ·Ö»¯°©,anaplastic thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÍâÊȸõϸ°ûÁö,Extra-adrenal pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ËèÑù°©,Medullary carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹Ìå´óÏÙÁö,pituitary macroadenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÂËÅÝ×´°©,follicular thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­°©»ùÒòc-met,proto-oncogene c-metÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾Þ´ó´¹ÌåÏÙÁö,giant pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°ûÖÜÆÚµ÷¿Øµ°°×,cell cycle regulatory proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÈ«Çгý,Total thyroidectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÂËÅݰ©,Thyroid follicular carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­µûÏÔ΢ÊÖÊõ,Transsphenoidal microsurgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙÀà°©,Thymic carcinoidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ýÑõ»¯ÎïøÌåÔöÖ³Òò×ӻÊÜÌå¦Ã,peroxisome proliferator-activated receptor ¦ÃÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÁÛ°©,thyroid squamous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÈéÍ·×´Ö×Áö,Thyroid papillary carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±ÁܰͽáÇåɨ,Neck dissectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­±ÇµûÍâ¿Æ,transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« S100A6µ°°×,S100A6 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈÚºÏÏÔÏñ,Fusion imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÈéÍ·×´ÔöÉú,Papillary thyroid hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Masaoka·ÖÆÚ,Masaoka stageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¢öÇøÁܰͽá,Region ¢ö lymph nodesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÏ¸°ûÔöÉú,Islet cell hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÖ×Áö/²¡Àíѧ,Adrenal gland neoplasms/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±²¿Áܰͽá×ªÒÆ,neck lymph node metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒìλÊȸõϸ°ûÁö,Ectopic pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈéÍ·×´ÔöÉú,papillary hyperplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±²¿ÁܰͽáÇåɨÊõ,Neck dissectionsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿ôÉÏËø¿×ÈË·,Supraorbital keyhole approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙÁܰÍÁö,Thymic lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ´ÎÈ«Çгý,Subtotal thyroidectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙ½Úϸ°ûÉñ¾­Áö,adrenal ganglioneuromaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²ÊÉ«¶àÆÕÀÕ³¬ÉùѪÁ÷ÏÔÏñ,Color Doppler flow imageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒþÄäÐÔ¼××´ÏÙ°©,Occult thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ô­·¢ÐÔÐØÏÙÁܰÍÁö,Primary thymic lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ¶ñÐÔÖ×Áö,Thyroid neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞ¹¦ÄÜÐÔÒȵºÏ¸°ûÁö/Õï¶Ï,Non-functional Islet Cell Tumor/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙÉÏÆ¤Ö×Áö,thymic epithelial tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾Þ´ó¼××´ÏÙÖ×Áö,the giant tumor ofthyroidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØ¹Çǰ¾¶Â·,Anterior chest approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ°©Ï¸°û,thyroid cancer cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÎÞ¹¦ÄÜÁö,Nonfunctioning adrenal adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÖ×Áö/Õï¶Ï,adrenal gland neplasms/DIÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙÉñ¾­ÄÚ·ÖÃÚ°©,thymic neuroendocrine carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ƤÏÂ×ªÒÆ,Subcutaneous metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú³¤¼¤ËØÁö,GH-secreting adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥±Ç¿×¾­µû,single-nostril transsphenoidalÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÖÊõÑ¡Ôñ,operational choicesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÏ¸°û/Õï¶Ï,islet cell/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÈËáϸ°û°©,oncocytic carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ñÐÔÒȵºËØÁö,Malignant insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×Áöϸ°ûºËÈËÊóǶºÏµ¥¿¹,Chimeric monoclonal antibody(chTNT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßЧҺÏàÉ«Æ×-µç»¯Ñ§·¨,HPLC ECDÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉÏÇ»¾²ÂöÖû»Êõ,Replacement of superior vena cavaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HBME-1µ°°×,HBME 1 proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Kϸ°û,NK cellsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼Ò×åÐÔÊȸõϸ°ûÁö,familial pheochromocytomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ú³¥ÐÔÔöÉú,compensatory renal growthÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ΢°©,thyroid microcancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÕïÁÆÌå»á,therapy practiceÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸£¶ûÂíÁ̶ֹ¨×éÖ¯,Tissue fixed in formalinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CT·ÂÕæÄÚ¿ú¾µ,CT virtual endoscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬ÉùͼÏñÌØÕ÷,Ultrasonic feataures invesligationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´©´Ìϸ°ûѧ¼ì²é,Fine needle aspiration cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ïûñ¨ÌÀ,Xiao Ying DecoctionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ö»¯Ðͼ××´ÏÙÖ×Áö,differentiated thyroid neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÓ¹¦ÄÜÕϰ­,visual function damageÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±í´ïʧ»î,expression silencingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«